Article
Prediction of chemo-response in serous ovarian cancer
19 Oct 2016
Abstract excerpt
BACKGROUND: Nearly one-third of serous ovarian cancer (OVCA) patients will not respond to initial treatment with surgery and chemotherapy and die within one year of diagnosis. If patients who are unlikely to respond to current standard therapy can be identified up front, enhanced tumor analyses and treatment regimens could potentially be offered. Using the Cancer Genome Atlas (TCGA) serous OVCA database, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
